Using a low median estimate of a 15% rate of PCP in those with fewer than 200 × 106 l−1 CD4 cells [34–36], an estimated 450 000 develop PCP annually among the 2 988 000 with a CD4 count less than 200 × 106 l−1. The gene discussed is CD4; the disease is pneumocystosis.